These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26417338)

  • 1. Impact of urinary bladder cancer risk variants on prognosis and survival.
    Selinski S
    EXCLI J; 2014; 13():1254-8. PubMed ID: 26417338
    [No Abstract]   [Full Text] [Related]  

  • 2. Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens.
    Cai T; Tiscione D; Verze P; Pomara G; Racioppi M; Nesi G; Barbareschi M; Brausi M; Gacci M; Luciani LG; Liguori G; Gontero P; Campodonico F; Simonato A; Boddi V; Di Stasi SM; Colombo R; Serretta V; Carmignani G; Malossini G; Altieri V; Carini M; Terrone C; Bassi P; Montorsi F; Ficarra V; Selli C; Mirone V; Bartoletti R
    Urology; 2014 Nov; 84(5):1141-6. PubMed ID: 25239253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China.
    Wang Q; Zhang T; Wu J; Wen J; Tao D; Wan T; Zhu W
    BMC Urol; 2019 Apr; 19(1):24. PubMed ID: 30999871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc transporter genes and urological cancers: integrated analysis suggests a role for ZIP11 in bladder cancer.
    Wu L; Chaffee KG; Parker AS; Sicotte H; Petersen GM
    Tumour Biol; 2015 Sep; 36(10):7431-7. PubMed ID: 25900876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative effect of genome-wide association study-identified genetic variants for bladder cancer.
    Wang M; Chu H; Lv Q; Wang L; Yuan L; Fu G; Tong N; Qin C; Yin C; Zhang Z; Xu J
    Int J Cancer; 2014 Dec; 135(11):2653-60. PubMed ID: 24740636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic impact of GSTM1/GSTP1 genetic variants in bladder Cancer.
    Albarakati N; Khayyat D; Dallol A; Al-Maghrabi J; Nedjadi T
    BMC Cancer; 2019 Oct; 19(1):991. PubMed ID: 31646988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.
    Kuroiwa K; Inokuchi J; Nishiyama H; Kojima T; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yokomizo A; Matsuyama H; Ichikawa T; Mizusawa J; Eba J; Naito S;
    J Urol; 2019 Dec; 202(6):1127-1135. PubMed ID: 31251717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
    Xylinas E; Rink M; Robinson BD; Lotan Y; Babjuk M; Brisuda A; Green DA; Kluth LA; Pycha A; Fradet Y; Faison T; Lee RK; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF
    Eur J Cancer; 2013 May; 49(8):1889-97. PubMed ID: 23466126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic diversity of urinary bladder cancer and the risk of recurrence based on mutation analysis.
    Traczyk-Borszynska M; Borkowska E; Jablonowski Z; Jedrzejczyk A; Pietrusinski M; Kaluzewski B; Sosnowski M; Borowiec M
    Neoplasma; 2016; 63(6):952-960. PubMed ID: 27596295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients.
    Moschini M; Shariat SF; Lucianò R; D'Andrea D; Foerster B; Abufaraj M; Bandini M; Dell'Oglio P; Damiano R; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
    Clin Genitourin Cancer; 2017 Aug; 15(4):e603-e607. PubMed ID: 28040422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer.
    Bielli P; Panzeri V; Lattanzio R; Mutascio S; Pieraccioli M; Volpe E; Pagliarulo V; Piantelli M; Giannantoni A; Di Stasi SM; Sette C
    Clin Cancer Res; 2018 Nov; 24(21):5422-5432. PubMed ID: 30012566
    [No Abstract]   [Full Text] [Related]  

  • 13. Usefulness of histologic homogeneity estimation of muscle-invasive urinary bladder cancer in an individual prognosis: a mapping study.
    Jozwicki W; Domaniewski J; Skok Z; Wolski Z; Domanowska E; Jozwicka G
    Urology; 2005 Nov; 66(5):1122-6. PubMed ID: 16286151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on urinary bladder pathology.
    Compérat E
    Cesk Patol; 2014; 50(4):129-36. PubMed ID: 25418899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups.
    Millán-Rodríguez F; Chéchile-Toniolo G; Salvador-Bayarri J; Huguet-Pérez J; Vicente-Rodríguez J
    J Urol; 2000 Oct; 164(4):1183-7. PubMed ID: 10992362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cancer of the urinary bladder: prognosis of the outcome].
    Zimichev AA; Prianichnikova MB; Maklakov VN
    Urologiia; 2009; (3):52-3. PubMed ID: 19673123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing survival of patients with urinary bladder cancer. A nationwide study in Sweden 1960-1986.
    Malmström PU; Thörn M; Lindblad P; Bergström R; Adami HO
    Eur J Cancer; 1993; 29A(13):1868-72. PubMed ID: 8260244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occupational bladder cancer: Polymorphisms of xenobiotic metabolizing enzymes, exposures, and prognosis.
    Lukas C; Selinski S; Prager HM; Blaszkewicz M; Hengstler JG; Golka K
    J Toxicol Environ Health A; 2017; 80(7-8):439-452. PubMed ID: 28696839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.
    Durkan GC; Nutt JE; Rajjayabun PH; Neal DE; Lunec J; Mellon JK
    Clin Cancer Res; 2001 Nov; 7(11):3450-6. PubMed ID: 11705862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.